Report states, [Cadient has] “a broader purview on the pharmaceutical marketing landscape”

West Conshohocken, Pa., June 22, 2006 – Cadient Group, the premiere strategic interactive marketing agency serving the healthcare industry, today announced that Forrester Research has recognized the company as a “Leader” in its industry report, “The Forrester Wave: KOL Management Platforms, Q2 2006.” ¹ Cadient was top-ranked in strategy consulting and profitability. The company also received high ratings for its strong relationship management and strategy capabilities. Cadient, along with seven other solutions providers were evaluated against 52 key criteria within the Forrester Wave Report.

According to Forrester’s evaluation, Cadient Group is an “especially good fit for companies that want support for a broader focus than just KOL management,” noting Cadient’s real strength lies in its “ability to tie larger KOL initiatives to a brand’s broader physician marketing efforts.” The report also noted that Cadient was “well suited for companies who view KOL management as a primarily marketing-driven initiative…because its system has closer ties to sales and marketing rather than clinical processes and systems.” ² Forrester conducted extensive research including examining past research, user needs assessments, and vendor and expert interviews. This evaluation further validates Cadient’s methodology of positioning interactive solutions at the core of a brand’s overall marketing mix to unify and, in turn, amplify traditional brand marketing components. The report, authored by Elizabeth W. Boehm, also stated that Cadient is “unusual in the KOL management platforms market in that it offers both strategy consulting and a robust suite of marketing applications built and managed in-house. [Cadient’s] solution set includes a relationship marketing platform as well as a content management and collaboration suite.” Forrester continued, “unlike any other vendors evaluated, Cadient’s consulting services range across an array of pharmaceutical marketing engagements, which aren’t focused solely on KOL management. This gives Cadient a broader purview on the pharmaceutical landscape and allows it to help clients determine when to employ KOLs and in what ways to best advance their brand initiatives.” ³

“Cadient is committed to and focused on elevating the strategic role of interactive marketing. Along with our innovative clients, we are shifting the industry’s silo-ed approach to marketing functions into a more interdependent and integrated whole,” said Stephen Wray, President and CEO, Cadient Group. “We’re especially proud of Forrester’s positive recognition of Cadient’s strategic capabilities, deep industry knowledge and ability to expertly counsel companies on how to best advance their brand initiatives.”

Earlier this year, Cadient launched its eDefining Healthcare Marketing^™ initiative with 12 individual points of view that illustrate how specific, traditional marketing vehicles are impacted and improved by leveraging an interactive core.

For further details on Cadient’s evaluation in The Forrester Wave: KOL Management Platforms, Q2 2006, please visit our microsite at: www.cadient.com/forresterwave.

About Cadient Group
Based in the Philadelphia region, a key locale for the global intersection of life sciences and technology, Cadient Group is a strategic interactive marketing agency that is eDefining Healthcare Marketing^™. The choice of top pharmaceutical and biopharmaceutical brands, Cadient Group blends pharmaceutical expertise, breakthrough strategic thinking, and proprietary technology into solutions that maximize the role, reach and ROI of healthcare eMarketing. It does so by helping pharma and biopharma companies intelligently integrate their interactive and online marketing into their overall brand strategies. By leveraging interactive marketing to connect brand strategies, Cadient is delivering consistent and sustainable returns while helping its customers to transform their approach to communications and marketing. The company has been entrusted with brands that exceed $30 billion dollars in combined annual sales. It has also partnered with the majority of the top 20 pharmaceutical and biopharmaceutical companies worldwide. For more information about Cadient Group, visit www.cadient.com.

Media Contacts:
Amber Link
Director, Corporate Communications
Cadient Group
pr@cadient.com
484.351.2800

Matt Helmke
Zer0 to 5ive
matt@0to5.com
610.368.8490

___________________________________________________
¹ The Forrester Wave™: KOL Management Platforms, Q2 2006 by Elizabeth W. Boehm (June 12, 2006)
² Cadient Augments KOL Management Strategy With Software Support, The Forrester Wave^™: Vendor Summary, Q2 2006 by Elizabeth W. Boehm (June 12, 2006)
³ Cadient Augments KOL Management Strategy With Software Support, The Forrester Wave^™: Vendor Summary, Q2 2006 by Elizabeth W. Boehm (June 12, 2006)